MarkusCharles PaulGrompeMD
Pediatrics • Portland, ORProfessor, Pediatrics, Oregon Health and Science University School of Medicine
Are you Dr. Grompe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5516
Summary
- Dr. Markus Grompe, MD is a pediatrician in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Texas, and Washington. He is affiliated with OHSU Hospital and is a Professor at Oregon Health and Science University School of Medicine.
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1984 - 1987
University of Ulm Faculty of MedicineClass of 1983
Certifications & Licensure
OR State Medical License 1992 - 2025
TX State Medical License 1988 - 1992
WA State Medical License 1986 - 1989- American Board of Medical Genetics and Genomics Clinical Biochemical/Molecular Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
Clinical Trials
- Study of NTBC for Tyrosinemia I Start of enrollment: 1998 Oct 01
Publications & Presentations
PubMed
- 139 citationsA DNA methylation atlas of normal human cell types.Netanel Loyfer, Judith Magenheim, Ayelet Peretz, Gordon Cann, Joerg Bredno
Nature. 2023-01-01 - 241 citationsBone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.Raphael Ceccaldi, Kalindi Parmar, Enguerran Mouly, Marc Delord, Jung Min Kim
Cell Stem Cell. 2012-07-06 - 34 citationsMYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia.Alfredo E. Rodriguez, Kaiyang Zhang, Anniina Färkkilä, Jessica Filiatrault, Chunyu Yang
Cell Stem Cell. 2021-01-07
Press Mentions
Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards with Leading Liver Disease and Cell and Gene Therapy ExpertsJune 27th, 2022- Ambys Completes $47 Million Series a Extension to Advance Liver Cell Therapy PlatformDecember 21st, 2021
- Tylenol-Based Gene Therapy Makes Treating Genetic Diseases a ‘Walk in the Park’June 15th, 2021
- Join now to see all
Grant Support
- Treatment Of Distal Tyrosine Pathway DisordersNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Transplantation Assay For Liver Repopulating CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2012
- Novel Sources Of Transplantable Beta-Cell ReplacementsNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Preclinical Testing Of Novel Therapies In FANational Heart, Lung, And Blood Institute2010–2011
- Pathophysiology And Treatment Of Fanconi'S AnemiaNational Heart, Lung, And Blood Institute2010–2011
- Cell RepositoryNational Heart, Lung, And Blood Institute2010–2011
- Administrative CoreNational Heart, Lung, And Blood Institute2010–2011
- Modeling Liver Metabolism With Patient-Specific IPS Derived HepatocytesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Novel Reagents For Beta Cell BiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Pathophysiology Of Distal Tyrosine Pathway DisordersNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
- Pre-Clinical Therapy For Fanconi AnemiaNational Heart, Lung, And Blood Institute2004–2008
- Core C- FA Cell Respository CoreNational Heart, Lung, And Blood Institute2004–2008
- Cell Therapy By In Vivo FusionNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
- Faseb Conference: Mechanisms Of Liver Growth And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Isolation Of Murine Pancreatic Liver Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Pathophysiology And Treatment Of Disorders In The DistalNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- Positional Cloning Of Fanc Genes &Models Of Fanconi AnemiaNational Heart, Lung, And Blood Institute1999–2002
- Core--Fanconi Anemia Cell RepositoryNational Heart, Lung, And Blood Institute1994–2002
- Creation &Analysis Of A Mouse Model Of TyrosinemiaNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
- Gene Mapping/Isolation By Chromosome Transfer And Positional CloningNational Heart, Lung, And Blood Institute1994–1998
- Transplantation Assay For Liver Repopulating CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1996
- Creation And Analysis Of A Mouse Model Of TyrosinemiaNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1996
- Creation Of A Mouse Model Of Tyrosinemia, Type 1Eunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1992
